Retraction: Tert-Butylhydroquinone Alleviates Early Brain Injury and Cognitive Dysfunction after Experimental Subarachnoid Hemorrhage: Role of Keap1/Nrf2/ARE Pathway
The PLOS One Editors · 2026
Read Retraction: Tert-Butylhydroquinone Alleviates Early Brain Injury and Cognitive Dysfunction after Experimental Subarachnoid Hemorrhage: Role of Keap1/Nrf2/ARE Pathway by The PLOS One Editors (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0355259.txt.
Description
RETRACTED: The PLOS One Editors issued this 2026 retraction notice, withdrawing an earlier rat study that had claimed a food preservative compound eased early brain injury after bleeding around the brain. Readers should not rely on that study's findings. Concerns centred on several figures and on how the animals were treated.
Editors found a control image that appeared reused, a protein band size that raised doubt about identity, and overlapping panels that undermined related counts. Pain relief, humane endpoints, and approval details had not been reported, and anaesthetic and fluid choices raised welfare worries. Original data were missing, so the concerns could not be cleared.
Catalog record
| CREATOR | The PLOS One Editors |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4236 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |